Larson Financial Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.67K Buy
+72
New +$4.98K ﹤0.01% 2904
2023
Q1
– Sell
-100
Closed -$4.1K – 1607
2022
Q4
$4.1K Buy
+100
New +$4.16K ﹤0.01% 1071

Other funds holding XPH

Larson Financial Group's XPH Position: Q3 2026 in Review

Larson Financial Group opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2026: 72 shares worth $4.67K. The stake represents ﹤0.01% of the portfolio and ranks #2904 among its holdings. This is a return to the name: Larson Financial Group previously reported a position in XPH as recently as Q4 2022.

Larson Financial Group first reported a position in XPH in Q4 2022 and has held it in 2 quarters since. 117 funds tracked by Wall St. Rank hold XPH as of Q3 2026.

  • Larson Financial Group held 72 shares of State Street SPDR S&P Pharmaceuticals ETF worth $4.67K as of Q3 2026.
  • State Street SPDR S&P Pharmaceuticals ETF was a new Larson Financial Group position in Q3 2026.
  • State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2904 holding.
  • Larson Financial Group first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2022 and has held it in 2 quarters since.
  • 117 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.